Reduction of virulence factor pyocyanin production in multidrug-resistant Pseudomonas aeruginosa. 2013

Katsuhiro Fuse, and Shigeru Fujimura, and Toshiaki Kikuchi, and Kazunori Gomi, and Yasuhiro Iida, and Toshihiro Nukiwa, and Akira Watanabe
Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Nosocomial infections caused by metallo-β-lactamase (MBL)-producing multidrug-resistant (MDR) Pseudomonas aeruginosa have become a worldwide problem. Pyocyanin, a representative pigment produced by P. aeruginosa, is the major virulence factor of this organismThe aim of this study was to investigate the pyocyanin-producing ability of MBL-producing MDR P. aeruginosa. A total of 50 clinical isolates of P. aeruginosa, including 20 MDR strains, were collected at 18 general hospitals in Japan. The chromaticity and luminosity produced by pyocyanin in each isolate were measured. The quantity of pyocyanin and the expression of the phzM and phzS genes coding a pyocyanin synthesis enzyme were measured. MDR strains showed a bright yellow-green, while non-MDR strains tended to show a dark blue-green. The quantities of pyocyanin in MBL-producing strains and non-producing strains were 0.015 ± 0.002 and 0.41 ± 0.10 μg, respectively. The expression of the phzM and phzS genes in the MDR strains was 11 and 14 %, respectively, of the expression in the non-MDR strains. When the MBL gene was transduced into P. aeruginosa and it acquired multidrug resistance, it was shown that the pyocyanin-producing ability decreased. The pathogenicity of MBL-producing MDR P. aeruginosa may be lower than that of non-MDR strains. These MBL-producing MDR strains may be less pathogenic than non-MDR strains. This may explain why MDR-P. aeruginosa is unlikely to cause infection but, rather, causes subclinical colonization only.

UI MeSH Term Description Entries
D008780 Methyltransferases A subclass of enzymes of the transferase class that catalyze the transfer of a methyl group from one compound to another. (Dorland, 28th ed) EC 2.1.1. Methyltransferase
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D011710 Pyocyanine Antibiotic pigment produced by Pseudomonas aeruginosa. Pyocyanin
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006899 Mixed Function Oxygenases Widely distributed enzymes that carry out oxidation-reduction reactions in which one atom of the oxygen molecule is incorporated into the organic substrate; the other oxygen atom is reduced and combined with hydrogen ions to form water. They are also known as monooxygenases or hydroxylases. These reactions require two substrates as reductants for each of the two oxygen atoms. There are different classes of monooxygenases depending on the type of hydrogen-providing cosubstrate (COENZYMES) required in the mixed-function oxidation. Hydroxylase,Hydroxylases,Mixed Function Oxidase,Mixed Function Oxygenase,Monooxygenase,Monooxygenases,Mixed Function Oxidases,Function Oxidase, Mixed,Function Oxygenase, Mixed,Oxidase, Mixed Function,Oxidases, Mixed Function,Oxygenase, Mixed Function,Oxygenases, Mixed Function
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial

Related Publications

Katsuhiro Fuse, and Shigeru Fujimura, and Toshiaki Kikuchi, and Kazunori Gomi, and Yasuhiro Iida, and Toshihiro Nukiwa, and Akira Watanabe
September 2012, International journal of antimicrobial agents,
Katsuhiro Fuse, and Shigeru Fujimura, and Toshiaki Kikuchi, and Kazunori Gomi, and Yasuhiro Iida, and Toshihiro Nukiwa, and Akira Watanabe
August 2016, Toxins,
Katsuhiro Fuse, and Shigeru Fujimura, and Toshiaki Kikuchi, and Kazunori Gomi, and Yasuhiro Iida, and Toshihiro Nukiwa, and Akira Watanabe
January 2006, Photochemistry and photobiology,
Katsuhiro Fuse, and Shigeru Fujimura, and Toshiaki Kikuchi, and Kazunori Gomi, and Yasuhiro Iida, and Toshihiro Nukiwa, and Akira Watanabe
January 2016, Beilstein journal of organic chemistry,
Katsuhiro Fuse, and Shigeru Fujimura, and Toshiaki Kikuchi, and Kazunori Gomi, and Yasuhiro Iida, and Toshihiro Nukiwa, and Akira Watanabe
January 2010, Archives of microbiology,
Katsuhiro Fuse, and Shigeru Fujimura, and Toshiaki Kikuchi, and Kazunori Gomi, and Yasuhiro Iida, and Toshihiro Nukiwa, and Akira Watanabe
August 2007, Journal of gastroenterology and hepatology,
Katsuhiro Fuse, and Shigeru Fujimura, and Toshiaki Kikuchi, and Kazunori Gomi, and Yasuhiro Iida, and Toshihiro Nukiwa, and Akira Watanabe
March 2012, The Journal of urology,
Katsuhiro Fuse, and Shigeru Fujimura, and Toshiaki Kikuchi, and Kazunori Gomi, and Yasuhiro Iida, and Toshihiro Nukiwa, and Akira Watanabe
April 2016, Journal of cellular and molecular medicine,
Katsuhiro Fuse, and Shigeru Fujimura, and Toshiaki Kikuchi, and Kazunori Gomi, and Yasuhiro Iida, and Toshihiro Nukiwa, and Akira Watanabe
January 2018, Current topics in medicinal chemistry,
Katsuhiro Fuse, and Shigeru Fujimura, and Toshiaki Kikuchi, and Kazunori Gomi, and Yasuhiro Iida, and Toshihiro Nukiwa, and Akira Watanabe
April 2017, FEMS microbiology letters,
Copied contents to your clipboard!